Bifidobacterium lactis and purpose thereof in acceleration of growth and development of children and adolescents
A technology of bifidobacterium lactis and teenagers, applied in the field of microorganisms, can solve problems such as low IQ, achieve the effect of improving metabolic disorders and promoting growth and development
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0049] This example is used to illustrate Bifidobacterium lactis BL-11 and its performance characteristics.
[0050] 1. Taxonomic characteristics of Bifidobacterium lactis BL-11:
[0051] Observing Bifidobacterium lactis BL-11 under a microscope, the results are as follows figure 1 shown. The physical and chemical test results are shown in Tables 1 and 2.
[0052] Table 1
[0053]
[0054] Table 2
[0055]
[0056] + means able to metabolize; - means unable to metabolize.
[0057] 2. Artificial gastric juice and intestinal juice tolerance of Bifidobacterium lactis BL-11:
[0058] Bifidobacteria are a genus of bacteria that are generally not acid fast. In this example, the tolerance of artificial gastric juice and intestinal juice of Bifidobacterium lactis BL-11 of the present invention is tested. At the same time, the Bifidobacterium lactis Bb which is currently preserved in the laboratory has excellent acid resistance and can survive through the gastrointestinal t...
Embodiment 2
[0068] This example is used to illustrate the functional characteristics of Bifidobacterium lactis BL-11 in promoting growth and development.
[0069] The microbiota, promotes bone formation as well as resorption, resulting in net bone growth. The microbiota induces the hormone-like insulin growth factor 1 (IGF-1), which promotes bone growth and remodeling. Short-chain fatty acids (SCFAs) produced by the microbiota fermenting fibers also induced IGF-1, suggesting a mechanism by which the microbiota affects bone health.
[0070] Two-month-old female BALB / c mice were treated with antibiotics and probiotics and housed under SPF conditions. Thirty mice were pooled and randomly assigned to treatment groups to minimize cage effects. Antibiotics were a mixture of 0.2 mg / mL gentamicin, 0.15 mg / mL ciprofloxacin, 2 mg / mL streptomycin and 1 mg / mL bacitracin.
[0071] First, the mice were treated with an antibiotic mixture added to their drinking water for 2 weeks to deplete the microo...
Embodiment 3
[0077] This example is used to illustrate the preparation of BL-11 bacterial powder and its use in food production.
[0078] The bifidobacterium lactis BL-11 provided by the invention is anaerobically cultured in MRS broth liquid medium. After primary, secondary and expanded culture, the fermentation broth was cultured at 37°C for 24h, then centrifuged at 4°C and 3000rpm for 10min to collect the bacteria, washed with phosphate buffer saline (PBS), added skim milk for freeze-drying , Store below -20°C.
[0079] The BL-11 bacterial powder prepared in this example can be used for food, medicine, health products or animal feed.
[0080] The food can be common food or health food such as fermented milk, cheese, milk beverage, solid beverage, milk powder, etc. Preferably, in the food, the recommended dose of Bifidobacterium lactis BL-11 for human use can be 1.0×10 3 CFU~1.0×10 10 CFU / kg body weight / day, more preferably 1.0×10 4 CFU~1.0×10 9 CFU / kg body weight / day.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com